Radiomics Nomogram Analyses for Differentiating Pneumonia and Acute Paraquat Lung Injury.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
21 10 2019
Historique:
received: 29 08 2018
accepted: 17 09 2019
entrez: 23 10 2019
pubmed: 23 10 2019
medline: 31 10 2020
Statut: epublish

Résumé

Paraquat poisoning has become a serious public health problem in some Asian countries because of misuse or suicide. We sought to develop and validate a radiomics nomogram incorporating radiomics signature and laboratory bio-markers, for differentiating bacterial pneumonia and acute paraquat lung injury. 180 patients with pneumonia and acute paraquat who underwent CT examinations between December 2014 and October 2017 were retrospectively evaluated for testing and validation. Clinical information including demographic data, clinical symptoms and laboratory test were also recorded. A prediction model was built by using backward logistic regression and presented on a nomogram. The radiomics-based features yielded areas under the receiver operating characteristic curve of 0.870 (95% CI 0.757-0.894), sensitivity of 0.857, specificity of 0.804, positive predictive value of 83.3%, negative predictive value of 0.818 in the primary cohort, while in the validation cohort the model showed similar results (0.865 (95% CI 0.686-0.907), 0.833, 0.792, 81.5%, respectively). The individualized nomogram included radiomics signature, body temperature, nausea and vomiting, and aspartate transaminase. We have developed a radiomics nomogram that combination of the radiomics features and clinical risk factors to differentiate paraquat lung injury and pneumonia for patients with an unclear medical history of exposure to paraquat poisoning, providing appropriate therapy decision support.

Identifiants

pubmed: 31636276
doi: 10.1038/s41598-019-50886-7
pii: 10.1038/s41598-019-50886-7
pmc: PMC6803642
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15029

Références

Clin Toxicol (Phila). 2009 Mar;47(3):226-9
pubmed: 18788002
Ann Acad Med Singap. 1987 Apr;16(2):300-2
pubmed: 3688804
PLoS One. 2017 May 18;12(5):e0177379
pubmed: 28545080
Korean J Intern Med. 2009 Sep;24(3):247-51
pubmed: 19721862
Vet Hum Toxicol. 1996 Feb;38(1):34-5
pubmed: 8825748
Clin Toxicol (Phila). 2012 Jul;50(6):471-80
pubmed: 22624660
Toxicology. 2009 Jan 31;255(3):187-93
pubmed: 19026709
Infect Immun. 1975 Apr;11(4):704-10
pubmed: 1120610
PLoS Med. 2008 Feb;5(2):e49
pubmed: 18303942
Br J Radiol. 2014 Oct;87(1042):20140369
pubmed: 25051978
J Am Soc Nephrol. 2012 Feb;23(2):322-33
pubmed: 22095948
J Clin Invest. 1984 Mar;73(3):842-7
pubmed: 6323529
Med Phys. 2011 Feb;38(2):915-31
pubmed: 21452728
Free Radic Biol Med. 2006 Oct 15;41(8):1213-24
pubmed: 17015168
Clin Microbiol Rev. 2004 Oct;17(4):697-728, table of contents
pubmed: 15489344
Clin Cancer Res. 2017 Aug 1;23(15):4259-4269
pubmed: 28280088

Auteurs

Wang Yanling (W)

Department of Medical Imaging, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Gao Duo (G)

Department of Medical Imaging, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Geng Zuojun (G)

Department of Medical Imaging, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China. 1980756261@qq.com.

Shi Zhongqiang (S)

GE Healthcare, Shanghai, 210000, China.

Wu Yankai (W)

Department of Medical Imaging, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Lu Shan (L)

Department of Medical Imaging, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Cui Hongying (C)

Department of Medical Imaging, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH